Alagille Syndrome Accelerator Award

The COVID-19 pandemic continues to evolve and impact our personal and professional lives. We want to assure our trustees, reviewers, and grantee communities that our TMF staff continues to provide high quality biomedical research grantmaking services. We will do our part to help manage any potential challenges and continue supporting research to the extent that it is possible. Please notify us with any questions or requests.



The Alagille Syndrome Accelerator Award was created to advance ongoing research towards a cure or improved therapeutic treatment of patients with Alagille Syndrome.  Projects must contribute to finding effective therapies or cures for Alagille Syndrome, or the discovery and testing of potential drugs directed at relevant pathways in animal models or support of exploratory small clinical studies in human volunteers.

A one-year $25,000 award will support an outstanding investigator working in a non-profit academic, medical, or research institution in North America. Funding begins September 15, 2019.


  • Applicants must hold an M.D. or Ph.D.
  • Project must be conducted at a non-profit institution in North America
  • Proposal must address discovery of effective therapies or cures for Alagille Syndrome